SCHEMBL25926563

SCHEMBL25926563

c1ccc(-c2nc(-c3ccccc3)nc(-c3ccc4c(c3)oc3cccc(-c5ccc6oc7ccc(-n8c9ccccc9c9ccccc98)cc7c6c5)c34)n2)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BACE1 P56817 1/20 0.33
CHEK2 O96017 1/20 0.32
PTGER4 P35408 1/20 0.32
HCRTR1 O43613 1/20 0.32
PLA2G2A P14555 2/20 0.32
PLA2G4A P47712 2/20 0.32
PLA2G10 O15496 1/20 0.32
PRKDC P78527 1/20 0.32
KDM4E B2RXH2 2/20 0.31
ATM Q13315 2/20 0.31
L3MBTL1 Q9Y468 2/20 0.31
SIRT2 Q8IXJ6 1/20 0.31
SIRT1 Q96EB6 1/20 0.31
ALOX5 P09917 1/20 0.31
PIM1 P11309 1/20 0.31
CSNK2A2 P19784 1/20 0.31
CSNK2B P67870 1/20 0.31
PIM3 Q86V86 1/20 0.31
PIM2 Q9P1W9 1/20 0.31
ALDH1A1 P00352 2/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25926553 0.98 PTGER4 (0.34) BACE1CHEK2PTGER4HCRTR1PRKDC
SCHEMBL25703380 0.97 PTGER4 (0.34) BACE1CHEK2PTGER4HCRTR1PLA2G2A
SCHEMBL25926631 0.97 PTGER4 (0.36) BACE1CHEK2PTGER4HCRTR1PLA2G2A
SCHEMBL25926562 0.97 PTGER4 (0.36) BACE1CHEK2PTGER4HCRTR1PLA2G2A
SCHEMBL25926537 0.97 PTGER4 (0.34) BACE1CHEK2PTGER4HCRTR1PLA2G2A
SCHEMBL24232640 0.97 PTGER4 (0.34) BACE1CHEK2PTGER4HCRTR1PLA2G2A
SCHEMBL25926535 0.97 PTGER4 (0.36) BACE1CHEK2PTGER4HCRTR1PLA2G2A
SCHEMBL24232675 0.97 PTGER4 (0.35) BACE1CHEK2PTGER4HCRTR1PLA2G2A
SCHEMBL23557951 0.96 PTGER4 (0.33) BACE1CHEK2PTGER4HCRTR1PRKDC
SCHEMBL24264008 0.96 PTGER4 (0.34) BACE1CHEK2PTGER4HCRTR1PLA2G2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230247902-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, AND COMPOSITION FOR ORGANIC LAYER OF ORGANIC LIGHT-EMITTING DEVICE LT MATERIALS CO., LTD. (KR) 2023-08-03 US disclosed
US-20230247902-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, AND COMPOSITION FOR ORGANIC LAYER OF ORGANIC LIGHT-EMITTING DEVICE LT MATERIALS CO., LTD. (KR) 2023-08-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230247902-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, AND COMPOSITION FOR ORGANIC LAYER OF ORGANIC LIGHT-EMITTING DEVICE CRY1, PPOX, ORC3 BACE1 47/4885CHEK2 1593/4885PTGER4 2825/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.